This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Sep;221(3):389.

doi: 10.2214/AJR.23.29011. Epub 2023 Jan 18.

Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy

Ryan D Ward¹, Andrei S Purysko^{1

2}

Affiliations

Affiliations

¹ Abdominal Imaging Section, Imaging Institute, Cleveland Clinic, Cleveland, OH.
² Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, JB-322, Cleveland, OH 44145.

PMID: 36651610
DOI: 10.2214/AJR.23.29011

Comment

Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy

Ryan D Ward et al. AJR Am J Roentgenol. 2023 Sep.

. 2023 Sep;221(3):389.

doi: 10.2214/AJR.23.29011. Epub 2023 Jan 18.

Authors

Ryan D Ward¹, Andrei S Purysko^{1

2}

Affiliations

¹ Abdominal Imaging Section, Imaging Institute, Cleveland Clinic, Cleveland, OH.
² Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, JB-322, Cleveland, OH 44145.

PMID: 36651610
DOI: 10.2214/AJR.23.29011

No abstract available

PubMed Disclaimer

Comment on

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study.
Hao S, Discacciati A, Eklund M, Heintz E, Östensson E, Elfström KM, Clements MS, Nordström T. Hao S, et al. JAMA Oncol. 2022 Nov 10;9(1):88-94. doi: 10.1001/jamaoncol.2022.5252. Online ahead of print. JAMA Oncol. 2022. PMID: 36355382 Free PMC article.

Similar articles

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H; STHLM3 study group. Nordström T, et al. Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13. Lancet Oncol. 2021. PMID: 34391509 Clinical Trial.
Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.
Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. Barnett CL, et al. BJU Int. 2018 Jul;122(1):50-58. doi: 10.1111/bju.14151. Epub 2018 Mar 8. BJU Int. 2018. PMID: 29388388
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A, Wilderäng U, Aus G, Carlsson S, Damber JE, Frånlund M, Geterud K, Khatami A, Socratous A, Stranne J, Hellström M, Hugosson J. Grenabo Bergdahl A, et al. Eur Urol. 2016 Oct;70(4):566-573. doi: 10.1016/j.eururo.2015.12.006. Epub 2015 Dec 24. Eur Urol. 2016. PMID: 26724840 Free PMC article. Clinical Trial.
Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro).
Maffei D, Giganti F, Moore CM. Maffei D, et al. Urol Oncol. 2023 Feb;41(2):88-91. doi: 10.1016/j.urolonc.2022.04.016. Epub 2022 Jul 22. Urol Oncol. 2023. PMID: 35871993 Review.
[Multiparametric MRI for prostate cancer screening].
Hoeks CM, Fütterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO. Hoeks CM, et al. Ned Tijdschr Geneeskd. 2009;153:B487. Ned Tijdschr Geneeskd. 2009. PMID: 20003566 Review. Dutch.

See all similar articles

Cited by

Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group.
Wang LJ, Jinzaki M, Tan CH, Oh YT, Shinmoto H, Lee CH, Patel NU, Chang SD, Westphalen AC, Kim CK. Wang LJ, et al. Korean J Radiol. 2023 Nov;24(11):1102-1113. doi: 10.3348/kjr.2023.0644. Korean J Radiol. 2023. PMID: 37899520 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal